The Fertility Panel – Female Package is a hormonal health screening package that includes 7 laboratory parameters to evaluate reproductive hormones, ovarian reserve indicators, thyroid function, and prolactin levels.
The package includes Prolactin, TSH, LH, AMH, Estradiol (E2), FSH, and Total Testosterone to help healthcare professionals investigate hormonal imbalances that may affect menstrual cycles, ovulation, and reproductive health.
This package may be suitable for women experiencing irregular periods, difficulty conceiving, suspected polycystic ovary syndrome (PCOS), or other fertility-related concerns.
Fasting
Not required
Report time
72–96 hours
Recommended for
Female
Age group
18+ years
Tests
3 tests
Parameters
7 parameters
Parameters measured (5)
About the Fertility Panel – Female Package
The Fertility Panel – Female Package is a blood test package designed to assess selected hormones involved in reproductive function, menstrual cycle regulation, and ovarian activity.
Also known as: Female Fertility Hormone Panel, Women's Fertility Screening Package, Female Reproductive Hormone Profile, Ovarian Reserve and Hormone Panel, Female Fertility Blood Test.
Female reproductive health is regulated by interactions between the brain, pituitary gland, ovaries, and thyroid gland.
Hormones such as FSH, LH, estradiol, and prolactin influence menstrual cycles and ovulation.
AMH provides information about ovarian reserve, while testosterone may help evaluate certain hormonal imbalances.
Thyroid function can also affect menstrual regularity and reproductive health.
The Fertility Panel – Female Package evaluates three important areas:
Reproductive Hormones: LH, FSH, Estradiol, AMH, and Total Testosterone.
Pituitary Function: Prolactin.
Thyroid Function: TSH.
These measurements may support the investigation of fertility-related concerns and menstrual abnormalities.
However, hormone tests alone cannot determine whether a woman can or cannot become pregnant. Fertility assessment may also require ultrasound, ovulation evaluation, fallopian tube assessment, and partner testing.
Prolactin
Prolactin is a hormone produced by the pituitary gland.
It plays an important role in breast development and milk production.
Elevated prolactin levels may interfere with normal ovulation and menstrual cycles.
High prolactin may be associated with:
• Irregular menstrual periods.
• Absent menstrual periods.
• Ovulatory dysfunction.
• Milk discharge unrelated to breastfeeding.
• Certain pituitary conditions.
Prolactin levels can also increase temporarily due to stress, sleep, pregnancy, and certain medications.
The Fertility Panel – Female Package may be suitable for:
• Women experiencing difficulty conceiving.
• Individuals with irregular menstrual cycles.
• Women with absent menstrual periods.
• People with suspected ovulatory dysfunction.
• Women requiring ovarian reserve assessment.
• Individuals with suspected PCOS.
• Women with symptoms of elevated prolactin.
• Individuals with suspected thyroid-related menstrual abnormalities.
• Women experiencing excess facial hair or persistent acne.
• Individuals planning selected fertility treatments.
• Women undergoing evaluation for possible ovarian insufficiency.
• Patients advised by a gynecologist or fertility specialist to undergo hormone testing.
Note: Not every woman requires all seven tests. Test selection and sample timing should be based on symptoms, medical history, and clinical recommendations.
It is a hormonal screening package containing seven parameters used to evaluate selected reproductive hormones, ovarian reserve indicators, prolactin, and thyroid function.
The package includes 7 parameters across 3 test groups.
No. Fasting is not required.
Yes. Anti-Müllerian Hormone (AMH) is included.
| Package name | Fertility Panel – Female Package |
|---|---|
| Location | Nashik |
| Sample type | Blood |
| Number of tests | 3 |
| Number of parameters | 7 |
| Home sample collection | Available |
| Fasting | Not required |
| Report time | 72–96 hours |
| Recommended age | 18+ years |
| Suitable for | Female |
TSH (Thyroid Stimulating Hormone)
TSH is produced by the pituitary gland and regulates thyroid hormone production.
Thyroid hormones influence metabolism and several reproductive processes.
Both hypothyroidism and hyperthyroidism may affect menstrual regularity and ovulation.
TSH testing may help identify thyroid dysfunction that requires further evaluation.
LH (Luteinizing Hormone)
Luteinizing Hormone is produced by the pituitary gland.
LH plays an important role in ovulation and reproductive hormone regulation.
During a normal menstrual cycle, a rise in LH triggers ovulation.
Abnormal LH levels may occur with certain ovarian or pituitary conditions.
LH is sometimes evaluated alongside FSH and other hormones when investigating irregular menstrual cycles or suspected PCOS.
However, an LH/FSH ratio alone cannot diagnose PCOS.
AMH (Anti-Müllerian Hormone)
Anti-Müllerian Hormone is produced by cells associated with developing ovarian follicles.
AMH is commonly used as a marker of ovarian reserve.
It provides information about the estimated quantity of remaining recruitable follicles.
AMH testing may be useful during fertility evaluation and assisted reproductive treatment planning.
Important: AMH does not directly measure egg quality and cannot reliably predict an individual's chance of natural pregnancy.
Low AMH does not mean pregnancy is impossible, and high AMH does not guarantee fertility.
Estradiol (E2)
Estradiol is an estrogen hormone primarily produced by the ovaries during reproductive years.
It plays an important role in menstrual cycle regulation, endometrial development, and reproductive function.
Estradiol levels change throughout the menstrual cycle.
Estradiol testing may help evaluate ovarian hormone production and menstrual abnormalities.
When interpreted alongside FSH, estradiol can provide additional information during selected fertility assessments.
FSH (Follicle Stimulating Hormone)
FSH is produced by the pituitary gland.
It stimulates ovarian follicle development and supports estrogen production.
FSH levels vary throughout the menstrual cycle.
FSH testing may help evaluate:
• Ovarian function.
• Selected menstrual irregularities.
• Suspected ovarian insufficiency.
• Certain fertility-related conditions.
FSH is commonly interpreted alongside estradiol and the menstrual cycle day.
Testosterone Total
Testosterone is an androgen hormone present in women at lower concentrations than in men.
It is produced by the ovaries and adrenal glands.
Elevated testosterone may occur with certain androgen-related conditions, including PCOS.
Testosterone testing may be recommended for women experiencing:
• Excess facial or body hair.
• Persistent acne.
• Irregular menstrual periods.
• Other signs of androgen excess.
Total testosterone results require careful interpretation because concentrations in women are relatively low and some laboratory methods have limitations.
Healthcare professionals may recommend this package to:
• Investigate selected causes of difficulty conceiving.
• Evaluate irregular menstrual cycles.
• Investigate absent menstrual periods.
• Assess suspected ovulatory dysfunction.
• Evaluate ovarian reserve indicators.
• Investigate suspected PCOS.
• Assess elevated prolactin levels.
• Evaluate thyroid-related menstrual abnormalities.
• Investigate selected hormonal imbalances.
• Support fertility treatment planning.
• Assess suspected ovarian insufficiency.
• Investigate symptoms of androgen excess.
• Determine whether additional fertility investigations are required.
Benefits of the Fertility Panel – Female Package
• Includes seven hormone-related parameters.
• Measures AMH.
• Includes FSH and LH.
• Evaluates estradiol levels.
• Measures prolactin.
• Includes TSH.
• Measures total testosterone.
• Supports investigation of menstrual irregularities.
• Provides information about selected ovarian reserve indicators.
• Helps evaluate possible ovulatory dysfunction.
• Supports investigation of hormonal abnormalities associated with PCOS.
• May help identify thyroid-related reproductive concerns.
• Provides information useful during selected fertility assessments.
• Supports individualized medical evaluation.
• Does not require fasting.
Preparation Before the Test
• Fasting: Not required.
• Menstrual Cycle: Inform the laboratory about the first day of your last menstrual period.
• Cycle Timing: FSH, LH, and estradiol are often assessed early in the menstrual cycle, commonly around days 2–5, when clinically indicated.
• AMH: AMH can generally be measured on any day of the menstrual cycle.
• Prolactin: Follow the laboratory's timing instructions. Stress, recent exercise, and breast stimulation may affect results.
• Hormonal Medication: Inform your healthcare provider if you take hormonal contraceptives or fertility medication.
• Thyroid Medication: Report thyroid medication use.
• Biotin Supplements: Inform the laboratory about biotin supplements because they may interfere with certain hormone assays.
• Pregnancy: Inform your healthcare provider if you are pregnant or pregnancy is possible.
• Previous Reports: Bring earlier hormone tests, ultrasound reports, or fertility-related medical records.
• Medical History: Mention PCOS, thyroid disorders, previous ovarian surgery, or other relevant conditions.
Do not stop prescribed medications without medical advice.
Healthy Tips for Female Reproductive Health
• Maintain a balanced and nutritious diet.
• Include adequate dietary protein.
• Maintain a healthy body weight.
• Participate in regular physical activity.
• Follow a consistent sleep schedule.
• Manage stress through healthy lifestyle practices.
• Avoid smoking and tobacco products.
• Limit alcohol consumption.
• Monitor menstrual cycle patterns.
• Seek medical advice for persistently irregular periods.
• Discuss preconception folic acid supplementation when planning pregnancy.
• Follow prescribed treatment for thyroid or hormonal conditions.
• Avoid unverified fertility supplements.
• Seek appropriate evaluation for persistent difficulty conceiving.
• Discuss reproductive health concerns with a qualified healthcare professional.
AMH provides information about ovarian reserve, particularly the estimated quantity of developing follicles. It does not directly measure egg quality.
Yes. Both Follicle Stimulating Hormone and Luteinizing Hormone are included.
No. It can support fertility evaluation, but infertility cannot be diagnosed or excluded using these hormone tests alone.
The hormone measurements may support evaluation of suspected PCOS, but diagnosis requires clinical assessment and sometimes additional investigations.
Yes. TSH is included.
Yes. Prolactin is included to assess selected pituitary hormone abnormalities that may affect menstrual cycles and ovulation.
FSH, LH, and estradiol are often measured around menstrual cycle days 2–5 when clinically indicated. The appropriate timing depends on the reason for testing.
AMH can generally be measured on any day of the menstrual cycle, although interpretation may be influenced by age, medication, and clinical circumstances.
No. Low AMH does not mean natural pregnancy is impossible. AMH alone cannot predict an individual's ability to conceive naturally.
Home blood sample collection may be available through OnHealth in supported locations, subject to partner laboratory availability and sample timing requirements.
Report turnaround time depends on the partner laboratory. Confirm the expected reporting time when booking.